Pipeline Watch: Phase III Read-Outs For Zanubrutinib, Surufatinib

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.  

Pipeline Watch regular column feature image

Open Media

The table above records the past week's changes to the progress of selected potential new products through the clinical trial...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Pipeline Watch

More from R&D